Johnson & Johnson claims its single-shot COVID-19 vaccine neutralises Delta variant, provides 8 month immunity



The Johnson & Johnson single-shot COVID-19 vaccine jab generated strong, persistent activity against the Delta variant and other highly prevalent SARS-CoV-2 viral variants, claims laboratory study.